Precision Oncology and Cancer Surgery, An issue of Hematology/Oncology Clinics
- 1 Edición, Volumen 40-5 - 17 de septiembre de 2026
- Última edición
- Editor: Jason K. Sicklick
- Idioma: Inglés
In this issue of Hematology/Oncology Clinics, guest editor Dr. Jason K. Sicklick brings his considerable expertise to the topic of Precision Oncology and Cancer Surgery.… Leer más
Descripción
Descripción
In this issue of Hematology/Oncology Clinics, guest editor Dr. Jason K. Sicklick brings his considerable expertise to the topic of Precision Oncology and Cancer Surgery. Top experts discuss key topics in this fast-changing field, bridging medical and surgical care, helping to shape multidisciplinary treatment planning, and reflecting broader trends such as intraoperative molecular imaging and biomarker-driven therapy timing.
Puntos claves
Puntos claves
- Contains 14 relevant, practice-oriented topics, including understanding the landscape of clinically available molecular testing; cost-effectiveness and the economics of genomic testing and molecularly matched therapies; tissue-agnostic cancer therapy approvals; immuno-oncology; targeted therapies, biologics, and immunotherapy in the neoadjuvant and adjuvant settings: perioperative risks; precision oncology in various specific surgeries; and more.
- Provides in-depth clinical reviews on precision oncology and cancer surgery, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
De interès para
De interès para
Oncology, hematology, surgical oncology
Índice
Índice
Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
Understanding the Landscape of Clinically Available Molecular Testing
Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies
Tissue-Agnostic Cancer Therapy Approvals
Immuno-Oncology: New Insights into Targets and Therapies
Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative Risks
Precision Oncology in Breast Cancer Surgery
Precision Oncology in Lung Cancer Surgery
Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery
Precision Oncology in Hepatopancreatobiliary Cancer Surgery
Precision Oncology in Melanoma and Skin Cancer Surgery
Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors
Precision Oncology in Pediatric Cancer Surgery
Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons
Understanding the Landscape of Clinically Available Molecular Testing
Cost-Effectiveness and the Economics of Genomic Testing and Molecularly Matched Therapies
Tissue-Agnostic Cancer Therapy Approvals
Immuno-Oncology: New Insights into Targets and Therapies
Targeted Therapies, Biologics, and Immunotherapy in the Neoadjuvant and Adjuvant Settings: Perioperative Risks
Precision Oncology in Breast Cancer Surgery
Precision Oncology in Lung Cancer Surgery
Precision Oncology in Gastrointestinal and Colorectal Cancer Surgery
Precision Oncology in Hepatopancreatobiliary Cancer Surgery
Precision Oncology in Melanoma and Skin Cancer Surgery
Precision Oncology in Soft Tissue Sarcomas and Gastrointestinal Stromal Tumors
Precision Oncology in Pediatric Cancer Surgery
Current Multidisciplinary Lymphoma and Myeloma Management for Surgeons
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 40-5
- Publicado: 17 de septiembre de 2026
- Idioma: Inglés
Sobre el editor
Sobre el editor
Jason K. Sicklick
Editor
Afiliaciones y experiencia
Professor of Surgery | Division of Surgical Oncology, Adjunct Professor | Department of Pharmacology, Executive Vice Chair of Research, Department of Surgery, Associate Program Director | General Surgery Residency Program, Leader, Sarcoma Disease Team | Moores, Cancer Center UC San Diego Health | UC San Diego School of Medicine, Department of Surgery | Division of Surgical Oncology Moores Cancer Center